—
Price
—
Market Cap
—
P/E Ratio
—
Forward P/E
—
EPS (TTM)
—
Dividend Yield
—
Cash
—
Total Debt
—
Shares Out
Institutional Ownership of Lifecore Biomedical Inc
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 3.2M | $17M | — | — |
Trading Activity for Lifecore Biomedical Inc
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q2 | |||||
| SELL | -9.8% | 3.2M | $17M | — | |
| 2026-Q1 | |||||
| SELL | -3.9% | 3.5M | $13M | — | |
| 2025-Q4 | |||||
| SELL | -0.3% | 3.7M | $30M | — | |
| 2025-Q2 | |||||
| BUY | +2.2% | 3.7M | $30M | — | |
| 2024-Q4 | |||||
| BUY | +62.2% | 3.6M | $27M | — | |
| 2024-Q3 | |||||
| BUY | +0.6% | 2.2M | $11M | — | |
| 2024-Q2 | |||||
| BUY | +3.4% | 2.2M | $11M | — | |
| 2024-Q1 | |||||
| SELL | -9.4% | 2.1M | $11M | — | |
| 2023-Q4 | |||||
| BUY | +7.9% | 2.4M | $15M | — | |
| 2023-Q3 | |||||
| BUY | +15.3% | 2.2M | $165M | — | |
| 2023-Q2 | |||||
| BUY | +83.9% | 1.9M | $184M | — | |
| 2023-Q1 | |||||
| BUY | NEW | 1.0M | $39M | — | |
Insider Trading for Lifecore Biomedical Inc
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.